Year archive

NFL Biosciences — 2022 filings

All 28 regulatory filings released by NFL Biosciences (ALNFL) in 2022, sourced directly from the official regulator.

28 Filings

2022 Period

2022 filings (28)

Filing	Released	Lang
NFL : nombre d'actions et droits de vote au 30.11.2022 Share Issue/Capital Change	2022-12-09	French
NFL BIOSCIENCES : AUTORISATION D’ESSAI CLINIQUE POUR DÉMONTRER LA COMPLÉMENTARITÉ DE NFL-101 AVEC LES AUTRES TRAITEMENTS DE SEVRAGE TABAGIQUE Regulatory Filings	2022-11-08	French
NFL BIOSCIENCES: CLINICAL TRIAL APPROVED TO DEMONSTRATE THE COMPLEMENTARITY OF NFL-101 WITH OTHER SMOKING CESSATION TREATMENTS Regulatory Filings	2022-11-08	English
NFL BIOSCIENCES: NEW PATENT APPLICATION ASSOCIATING NFL-101 WITH OTHER SMOKING CESSATION TREATMENTS Investor Presentation	2022-11-02	English
NFL BIOSCIENCES : NOUVELLE DEMANDE DE BREVET ASSOCIANT NFL-101 AUX AUTRES TRAITEMENTS DE SEVRAGE TABAGIQUE Regulatory Filings	2022-11-02	French
NFL BIOSCIENCES : Rapport financier semestriel au 30 juin 2022 Interim / Quarterly Report H2 2022	2022-10-26	French
NFL Biosciences : Activités & Résultats du 1er semestre 2022 Earnings Release H1 2022	2022-10-25	French
NFL Biosciences: 2022 first-half business and earnings Earnings Release H2 2022	2022-10-25	English
NFL BIOSCIENCES CONCLUT UN PARTENARIAT AVEC THEMIS MEDICARE POUR LE DÉVELOPPEMENT DE NFL-101 EN INDE Regulatory Filings	2022-10-05	French
NFL BIOSCIENCES PARTNERS WITH THEMIS MEDICARE FOR THE DEVELOPMENT OF NFL-101 IN INDIA Regulatory Filings	2022-10-05	English
NFL BIOSCIENCES BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2022 Transaction in Own Shares	2022-07-26	French
NFL BIOSCIENCES HALF-YEAR REVIEW OF THE LIQUIDITY AGREEMENT FOR H1 2022 Transaction in Own Shares H1 2022	2022-07-26	English
NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME Regulatory Filings	2022-07-11	French
NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE Regulatory Filings	2022-06-24	French
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE Investor Presentation	2022-06-24	English
NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai Regulatory Filings	2022-05-25	French
NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31 Regulatory Filings	2022-05-25	English
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud Regulatory Filings	2022-05-11	French
NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea Regulatory Filings	2022-05-11	English
NFL Biosciences : RAPPORT ANNUEL au 31 décembre 2021 Annual Report FY 2021	2022-04-29	French
NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021 Report Publication Announcement	2022-04-29	French
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine Regulatory Filings	2022-04-11	French
NFL BIOSCIENCES: Notice of allowance of its patent in China Regulatory Filings	2022-04-11	English
NFL Biosciences : Activités & Résultats annuels 2021 Earnings Release FY 2021	2022-03-28	French
NFL BIOSCIENCES: co-development agreement for a drug candidate to reduce alcohol consumption Regulatory Filings	2022-02-02	English
NFL BIOSCIENCES : accord de co-développement d’un candidat médicament pour réduire la consommation d’alcool Regulatory Filings	2022-02-02	French
Nfl Biosciences: Half-Year Review of the Liquidity Agreement for h2 2021 Transaction in Own Shares H2 2021	2022-01-12	English
NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S2 2021 Transaction in Own Shares	2022-01-12	French